Our Mission: Highlighting Innovations by showcasing breakthroughs in cancer research, including diagnostic tools, therapies, and preventive measures.

Ovarian

Biomarker discovery and PARP inhibitors have opened new frontiers in treatment. Efforts in early detection through genetic screening are showing promising results.

Pharmabiz

TROPION-Lung12 phase 3 trial initiated evaluating Datroway as part of adjuvant regimen for patients with early-stage NSCLC at high risk of relapse

he first patient has been dosed in the TROPION-Lung12 phase 3 trial evaluating the efficacy and safety of adjuvant Datroway (datopotamab deruxtecan) plus rilvegostomig or rilvegostomig monotherapy versus standard of care in patients with stage 1 adenocarcinoma non-small cell lung cancer (NSCLC) after complete surgical resection who are ctDNA-positive or have other high risk pathological features.

Read More »
KNOW RIDGE

AI lasers may help detect breast cancer very early

Detecting breast cancer in its very early stages is often difficult with traditional mammograms, but a promising new technology could change that. Scottish researchers have combined artificial intelligence (AI) with advanced laser analysis to identify subtle changes in blood that may indicate the earliest signs of breast cancer. This breakthrough, published in the Journal of Biophotonics, […]

Read More »
error: Content is protected !!